SNYR vs CLAR

For growth investors, Clarus Corporation (CLAR) is the stronger pick with -4.

6% revenue growth year-over-year, versus -18. 6% for Synergy CHC Corp. (SNYR). Synergy CHC Corp. (SNYR) offers the better valuation at 1. 4x trailing P/E, making it the more compelling value choice. Analysts rate Clarus Corporation (CLAR) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Synergy CHC Corp.

(SNYR) delivered a total return of +10. 4%, compared to -82. 8% for Clarus Corporation (CLAR). Over 10 years, the gap is even starker: CLAR returned -13. 5% versus SNYR's -94. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Synergy CHC Corp.

(SNYR) is the lower-risk stock at 0. 79β versus Clarus Corporation's 1. 34β — meaning CLAR is approximately 71% more volatile than SNYR relative to the S&P 500.

By revenue growth (latest reported year), Clarus Corporation (CLAR) is pulling ahead at -4.

6% versus -18. 6% for Synergy CHC Corp. (SNYR). On earnings-per-share growth, the picture is similar: Synergy CHC Corp. grew EPS 297. 2% year-over-year, compared to 11. 7% for Clarus Corporation. Over a 3-year CAGR, SNYR leads at -4. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Synergy CHC Corp.

(SNYR) is the more profitable company, earning 6. 1% net margin versus -18. 5% for Clarus Corporation — meaning it keeps 6. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNYR leads at 16. 7% versus -8. 2% for CLAR. At the gross margin level — before operating expenses — SNYR leads at 67. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, CLAR (3.

5% yield) pays a dividend. SNYR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Clarus Corporation (CLAR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (3.

5% yield). Both have compounded well over 10 years (CLAR: -13. 5%, SNYR: -94. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SNYR (Healthcare) and CLAR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SNYR is a small-cap deep-value stock; CLAR is a small-cap income-oriented stock. CLAR pays a dividend while SNYR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.